rs139391205
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_006087.4(TUBB4A):āc.585T>Cā(p.Asn195=) variant causes a synonymous change. The variant allele was found at a frequency of 0.000445 in 1,614,194 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0024 ( 3 hom., cov: 32)
Exomes š: 0.00024 ( 2 hom. )
Consequence
TUBB4A
NM_006087.4 synonymous
NM_006087.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 6.70
Genes affected
TUBB4A (HGNC:20774): (tubulin beta 4A class IVa) This gene encodes a member of the beta tubulin family. Beta tubulins are one of two core protein families (alpha and beta tubulins) that heterodimerize and assemble to form microtubules. Mutations in this gene cause hypomyelinating leukodystrophy-6 and autosomal dominant torsion dystonia-4. Alternate splicing results in multiple transcript variants encoding different isoforms. A pseudogene of this gene is found on chromosome X. [provided by RefSeq, Jan 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 19-6495914-A-G is Benign according to our data. Variant chr19-6495914-A-G is described in ClinVar as [Benign]. Clinvar id is 513776.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-6495914-A-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00244 (372/152302) while in subpopulation AFR AF= 0.00849 (353/41564). AF 95% confidence interval is 0.00776. There are 3 homozygotes in gnomad4. There are 187 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 372 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TUBB4A | NM_006087.4 | c.585T>C | p.Asn195= | synonymous_variant | 4/4 | ENST00000264071.7 | NP_006078.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TUBB4A | ENST00000264071.7 | c.585T>C | p.Asn195= | synonymous_variant | 4/4 | 1 | NM_006087.4 | ENSP00000264071 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00244 AC: 371AN: 152184Hom.: 3 Cov.: 32
GnomAD3 genomes
AF:
AC:
371
AN:
152184
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000652 AC: 164AN: 251496Hom.: 2 AF XY: 0.000515 AC XY: 70AN XY: 135922
GnomAD3 exomes
AF:
AC:
164
AN:
251496
Hom.:
AF XY:
AC XY:
70
AN XY:
135922
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000237 AC: 346AN: 1461892Hom.: 2 Cov.: 33 AF XY: 0.000199 AC XY: 145AN XY: 727248
GnomAD4 exome
AF:
AC:
346
AN:
1461892
Hom.:
Cov.:
33
AF XY:
AC XY:
145
AN XY:
727248
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00244 AC: 372AN: 152302Hom.: 3 Cov.: 32 AF XY: 0.00251 AC XY: 187AN XY: 74460
GnomAD4 genome
AF:
AC:
372
AN:
152302
Hom.:
Cov.:
32
AF XY:
AC XY:
187
AN XY:
74460
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 13, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2022 | TUBB4A: BS1, BS2 - |
Hypomyelinating leukodystrophy 6 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 18, 2023 | - - |
TUBB4A-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 11, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at